{"entity":{"type":"insider","cik":"0001849458","url":"/insider/0001849458","json_url":"/insider/0001849458.json","name":"Tanguler Tolga","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":129,"n_filings":17,"first":"2022-07-07","last":"2026-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Tanguler Tolga","source":"filing","n_filings":17,"first_seen":"2022-07-07","last_seen":"2026-03-06"}],"transactions":[{"id":5935064,"accession":"0001735276-26-000060","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000060","line_url":"/filing/0001735276-26-000060","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2309.0,"shares_display":"2,309","price_per_share":323.0765829363361,"price_display":"323.08","price_state":"stated","total_value":745983.83,"total_display":"745,983.83","total_whole":"745,984","shares_owned_after":34777.0,"shares_owned_after_display":"34,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":8},{"id":6046228,"accession":"0001735276-26-000050","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000050","line_url":"/filing/0001735276-26-000050","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1598.0,"shares_display":"1,598","price_per_share":327.64942428035044,"price_display":"327.65","price_state":"stated","total_value":523583.78,"total_display":"523,583.78","total_whole":"523,584","shares_owned_after":37417.0,"shares_owned_after_display":"37,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":10},{"id":5935048,"accession":"0001735276-26-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000027","line_url":"/filing/0001735276-26-000027#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1959.0,"shares_display":"1,959","price_per_share":310.0808,"price_display":"310.08","price_state":"stated","total_value":607448.2872,"total_display":"607,448.29","total_whole":"607,448","shares_owned_after":31769.0,"shares_owned_after_display":"31,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-17","scope":"insider"},{"id":5840594,"accession":"0001735276-26-000012","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001735276-26-000012","line_url":"/filing/0001735276-26-000012","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1510.0,"shares_display":"1,510","price_per_share":362.86581456953644,"price_display":"362.87","price_state":"stated","total_value":547927.38,"total_display":"547,927.38","total_whole":"547,927","shares_owned_after":30020.0,"shares_owned_after_display":"30,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider","n_lines":21},{"id":4891878,"accession":"0001735276-25-000115","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":319.0,"shares_display":"319","price_per_share":452.69,"price_display":"452.69","price_state":"stated","total_value":144408.11,"total_display":"144,408.11","total_whole":"144,408","shares_owned_after":27818.0,"shares_owned_after_display":"27,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891875,"accession":"0001735276-25-000115","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":450.81,"price_display":"450.81","price_state":"stated","total_value":117210.6,"total_display":"117,210.60","total_whole":"117,211","shares_owned_after":28296.0,"shares_owned_after_display":"28,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891871,"accession":"0001735276-25-000115","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159.0,"shares_display":"159","price_per_share":451.86,"price_display":"451.86","price_state":"stated","total_value":71845.74,"total_display":"71,845.74","total_whole":"71,846","shares_owned_after":28137.0,"shares_owned_after_display":"28,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891867,"accession":"0001735276-25-000115","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157.0,"shares_display":"157","price_per_share":453.77,"price_display":"453.77","price_state":"stated","total_value":71241.89,"total_display":"71,241.89","total_whole":"71,242","shares_owned_after":27661.0,"shares_owned_after_display":"27,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891857,"accession":"0001735276-25-000115","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119.0,"shares_display":"119","price_per_share":449.79,"price_display":"449.79","price_state":"stated","total_value":53525.01,"total_display":"53,525.01","total_whole":"53,525","shares_owned_after":28556.0,"shares_owned_after_display":"28,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891854,"accession":"0001735276-25-000115","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117.0,"shares_display":"117","price_per_share":454.84,"price_display":"454.84","price_state":"stated","total_value":53216.28,"total_display":"53,216.28","total_whole":"53,216","shares_owned_after":27544.0,"shares_owned_after_display":"27,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891850,"accession":"0001735276-25-000115","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86.0,"shares_display":"86","price_per_share":448.77,"price_display":"448.77","price_state":"stated","total_value":38594.22,"total_display":"38,594.22","total_whole":"38,594","shares_owned_after":28675.0,"shares_owned_after_display":"28,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891846,"accession":"0001735276-25-000115","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70.0,"shares_display":"70","price_per_share":457.43,"price_display":"457.43","price_state":"stated","total_value":32020.1,"total_display":"32,020.10","total_whole":"32,020","shares_owned_after":27439.0,"shares_owned_after_display":"27,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891842,"accession":"0001735276-25-000115","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55.0,"shares_display":"55","price_per_share":446.53,"price_display":"446.53","price_state":"stated","total_value":24559.15,"total_display":"24,559.15","total_whole":"24,559","shares_owned_after":28788.0,"shares_owned_after_display":"28,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4891838,"accession":"0001735276-25-000115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-25-000115","line_url":"/filing/0001735276-25-000115#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001849458","owner_name":"Tanguler Tolga","owner_display_name":"Tanguler Tolga","owner_url":"/insider/0001849458","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35.0,"shares_display":"35","price_per_share":455.82,"price_display":"455.82","price_state":"stated","total_value":15953.7,"total_display":"15,953.70","total_whole":"15,954","shares_owned_after":27509.0,"shares_owned_after_display":"27,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"}],"collapsed":true,"next_cursor":"2025-10-02|4891838","ledger_fault":false,"count":{"value":129,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":129,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":129},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (EVP, Chief Commercial Officer)","n_filings":17,"first_seen":"2022-07-07","last_seen":"2026-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001849458","retrieved_at":"2026-08-26T19:47:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}